Salient Bio

London, United Kingdom

Salient Bio is a metagenomics and machine-learning enabled diagnostic and wellness test developer.

$3.2M raised

Sep 2025

Seed

Top Investors

THENA CapitalVanneck EIS

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Salient Bio raised?

Salient Bio has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in September 2025.

Who are Salient Bio's investors?

Salient Bio's investors include THENA Capital, Vanneck EIS.

Where is Salient Bio headquartered?

Salient Bio is headquartered in London, United Kingdom.

What does Salient Bio do?

Salient Bio is a metagenomics and machine-learning enabled diagnostic and wellness test developer.

What stage is Salient Bio at?

Salient Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 3, 2025.

MLA

"Salient Bio — Funding & Investors." VCBacked, September 3, 2025, https://www.vcbacked.co/company/salient-bio. Accessed June 17, 2026.

APA

VCBacked. (2025). Salient Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/salient-bio

Wikipedia (cite web)

{{cite web |title=Salient Bio — Funding & Investors |url=https://www.vcbacked.co/company/salient-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 3, 2025.